| Patient | Lou Gehrig |
|---|---|
| Date of birth | 1990-06-19 |
| Identifiers | MRN HR-ET018-SYN; SSN (made up) 000-18-6620 |
| Document date | 2026-05-04 |
| Author | Gavin Hollister, MD |
| Custodian | St. Posthumous Health Center |
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
New patient with progressive weakness and loss of coordination: evaluation for a motor neuron disorder and its mimics, safety, and how he wants to receive results [S]
This fictional modern episode addresses the presenting concerns below. [S]
Historical basis. These claims are historical evidence, not findings from a modern examination.
5 later historical claims are omitted because they describe events after the index age. See the teaching note.
Historical biography with true dates. These events are not part of the synthetic care timeline.
| Historical date | History | Evidence |
|---|---|---|
| 1938 | Lumbago and a badly jammed thumb during the season | D (CLM-0005) |
| During his playing career | Repeated head injuries, including concussions | D (CLM-0012) |
| Relative | Condition | Age at death | Evidence |
|---|---|---|---|
| sister | Died in infancy at about three months; cause not recorded in the cited source | D (CLM-0002) | |
| sister | Died in early childhood of measles, diphtheria and bronchopneumonia | D (CLM-0002) | |
| brother | Died shortly after birth; cause not recorded in the cited source | D (CLM-0002) |
| Allergy | Reaction | Status | Evidence |
|---|---|---|---|
| No known allergy | active | S |
Positive for the concerns in the history of present illness. Alert, quiet and courteous; frustrated and worried by his loss of strength; PHQ-2 1. No other systems reported as affected in this synthetic episode. [S]
Alert and engaged. Independent in all daily activities, but slow with buttons and laces; climbs stairs holding the rail; walks without an aid and trips on curbs now and then. [S]
Vital signs recorded on 2026-05-04; see the Vital Signs section. Mental status: Alert, quiet and courteous; frustrated and worried by his loss of strength; PHQ-2 1. The physical examination is limited to the findings relevant to this synthetic episode. [S]
| Date | Measure | Value | Unit | Provenance |
|---|---|---|---|---|
| 2026-05-04 | Body height | 183 | cm | S |
| 2026-05-04 | Body weight | 89.5 | kg | S |
| 2026-05-04 | Body mass index (BMI) [Ratio] | 26.7 | kg/m2 | S |
| 2026-05-04 | Systolic blood pressure | 124 | mm[Hg] | S |
| 2026-05-04 | Diastolic blood pressure | 78 | mm[Hg] | S |
| 2026-05-04 | Heart rate | 68 | /min | S |
| 2026-05-04 | Respiratory rate | 14 | /min | S |
| 2026-05-04 | Body temperature | 36.7 | Cel | S |
| 2026-05-04 | Oxygen saturation in Arterial blood by Pulse oximetry | 98 | % | S |
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
|---|---|---|---|---|---|---|
| 2026-05-04 | Leukocytes [#/volume] in Blood by Automated count | 6.8 | 10*3/uL | 4-11 10*3/uL | Normal | S |
| 2026-05-04 | Hemoglobin [Mass/volume] in Blood | 15.2 | g/dL | 13.2-17.1 g/dL | Normal | S |
| 2026-05-04 | Platelets [#/volume] in Blood by Automated count | 245 | 10*3/uL | 150-400 10*3/uL | Normal | S |
| 2026-05-04 | Sodium [Moles/volume] in Serum or Plasma | 140 | mmol/L | 135-145 mmol/L | Normal | S |
| 2026-05-04 | Potassium [Moles/volume] in Serum or Plasma | 4.4 | mmol/L | 3.5-5.1 mmol/L | Normal | S |
| 2026-05-04 | Creatinine [Mass/volume] in Serum or Plasma | 0.88 | mg/dL | 0.74-1.35 mg/dL | Normal | S |
| 2026-05-04 | Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M | 115 | mL/min/{1.73_m2} | >=60 mL/min/1.73 m² | Normal | S |
| 2026-05-04 | Glucose [Mass/volume] in Serum or Plasma | 92 | mg/dL | 70-99 mg/dL | Normal | S |
| 2026-05-04 | Calcium [Mass/volume] in Serum or Plasma | 9.4 | mg/dL | 8.6-10.3 mg/dL | Normal | S |
| 2026-05-04 | Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma | 32 | U/L | 7-55 U/L | Normal | S |
| 2026-05-04 | Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma | 30 | U/L | 10-40 U/L | Normal | S |
| 2026-05-04 | Creatine kinase [Enzymatic activity/volume] in Serum or Plasma | 412 | U/L | 39-308 U/L | High | S |
| 2026-05-04 | Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma | 512 | pg/mL | 232-1245 pg/mL | Normal | S |
| 2026-05-04 | Thyrotropin [Units/volume] in Serum or Plasma | 1.6 | m[IU]/L | 0.45-4.5 mIU/L | Normal | S |
| 2026-05-04 | Hemoglobin A1c/Hemoglobin.total in Blood | 5.2 | % | Below 5.7% is normal; 5.7 to 6.4% prediabetes | Normal | S |
| 2026-05-04 | Forced vital capacity [Volume] Respiratory system | 4.62 | L | >=4.1 L | Normal | S |
| 2026-05-04 | FVC measured/predicted | 90 | % | 80% of predicted or more is normal; noninvasive ventilation is considered below 50% | Normal | S |
| 2026-05-04 | Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] | 1 | {score} | S |
| Problem | Clinical status | Verification | Code | Provenance |
|---|---|---|---|---|
| Progressive weakness and loss of coordination for about a year: fumbling with buttons and a bat, tripping on curbs, a fall on the ice in the winter, muscle cramps and twitching in the arms and thighs; no numbness, pain, double vision, or trouble speaking or swallowing. Examination: wasting of the hand muscles (left more than right), fasciculations in both arms and thighs, weakness of grip and of left ankle dorsiflexion, brisk reflexes with spread and a positive Hoffmann sign, normal sensation. Mixed upper and lower motor neuron signs; evaluation for motor neuron disease and its mimics begun, with neuromuscular neurology consultation booked | active | confirmed | M62.81 | S — Synthetic presenting problem anchored to his documented decline in 1938 and 1939; superseded by the diagnosis. |